Generate a tailored SOP for Dr. Christian Grimm. Improve your application with a focused, well-structured draft.
Christian Grimm is a leading researcher in the field of organelle biology and pharmacology. He joined the Department of Pharmacology at the University of Oxford on April 1st, taking on a 50% Full-Time Equivalent (FTE) appointment while also retaining a 50% position at the Walther Straub Institute of Pharmacology and Toxicology at Ludwig-Maximilians-Universität Munich. He completed his PhD at the University of Berlin in 2004, followed by postdoctoral research at Harvard and Stanford Universities. Christian has industrial experience with Bayer and Pfizer, focusing his research on intracellular and endolysosomal ion channels as novel targets for disease therapy, particularly those related to lysosomal dysfunction. His areas of interest include the physiology and pathophysiology of diseases associated with lysosomal dysfunction, including metabolic and neurodegenerative diseases as well as lysosomal storage disorders. He currently leads the development of the Centre for Organelle Drug Discovery at the University of Oxford's Department of Pharmacology.
University of Oxford • Oxford, England
Leading research in organelle biology and pharmacology.
Walther Straub Institute of Pharmacology and Toxicology, LMU Munich • Munich, Germany
Conducting research with a focus on intracellular and endolysosomal ion channels.
Department of Politics and International Relations - Higher Level English requirement.